Verastem, Inc. (NASDAQ:VSTM)

CAPS Rating: 4 out of 5

Results 1 - 7 of 7

Recs

0
Member Avatar clangmead (60.73) Submitted: 2/11/2016 9:38:59 AM : Outperform Start Price: $1.13 VSTM Score: +33.16

mpor1

Recs

1
Member Avatar PrototypeZ (26.97) Submitted: 1/6/2016 11:34:59 AM : Outperform Start Price: $10.22 VSTM Score: -83.10

Bio lemming pick zz

Recs

0
Member Avatar oscillation (41.05) Submitted: 12/20/2015 2:48:48 AM : Outperform Start Price: $1.75 VSTM Score: -8.16

nev

Recs

0
Member Avatar Haugurafpeningum (26.66) Submitted: 5/4/2015 7:07:17 AM : Outperform Start Price: $8.58 VSTM Score: -78.45

Insider Monkey. Improving OBV

Recs

0
Member Avatar akamaidude (< 20) Submitted: 1/10/2014 10:09:15 PM : Outperform Start Price: $13.57 VSTM Score: -100.15

Promising technology and approach for cancer treatment and cure.

Recs

0
Member Avatar rknapton (63.79) Submitted: 8/22/2013 5:22:16 PM : Underperform Start Price: $14.67 VSTM Score: +112.64

Short. No revenues… if gets some might change to neutral.

Recs

0
Member Avatar cowman1 (< 20) Submitted: 1/24/2013 4:26:15 PM : Outperform Start Price: $10.21 VSTM Score: -121.50

USB analyst Matthew Roden thinks the company has a formular likely to prove crucial in the fight against many types of cancer.

Results 1 - 7 of 7

Featured Broker Partners